PON1 antibody

Product Graph
Contáctenos para saber el precio

Por favor contáctenos para obtener información detallada sobre el precio y disponibilidad.

935106861
info@markelab.com
name
PON1 antibody
category
Primary Antibodies
provider
FineTest
reference
FNab06638
tested applications
ELISA, WB, IHC, IP

Description

Hydrolyzes the toxic metabolites of a variety of organophosphorus insecticides. Capable of hydrolyzing a broad spectrum of organophosphate substrates and lactones, and a number of aromatic carboxylic acid esters. Mediates an enzymatic protection of low density lipoproteins against oxidative modification and the consequent series of events leading to atheroma formation.

Documents del producto

Instrucciones
Descargar
Data sheet
Descargar

Product specifications

Category
Primary Antibodies
Immunogen Target
paraoxonase 1 (PON1)
Host
Rabbit
Reactivity
Human, Mouse, Rat
Recommended Dilution
WB: 1:200-1:2000; IP: 1:200-1:2000; IHC: 1:20-1:200
Clonality
polyclonal
Conjugation
Unconjugated
Isotype
IgG
Observed MW
42-45 kDa
Purity
≥95% as determined by SDS-PAGE
Purification
Immunogen affinity purified
Size 1
100µg
Form
liquid
Tested Applications
ELISA, WB, IHC, IP
Storage
PBS with 0.02% sodium azide and 50% glycerol pH 7.3, -20℃ for 12 months(Avoid repeated freeze / thaw cycles.)
UniProt ID
P27169
Gene ID
5444
Alias
Serum paraoxonase/arylesterase 1 (PON 1),Aromatic esterase 1 (A-esterase 1),K-45,Serum aryldialkylphosphatase 1,PON1,PON
Background
Antibody anti-PON1
Status
RUO
Note
Mol. Weight 42-45 kDa

Descripción

Related Products

EH0257

Human PON1 (Serum paraoxonase/arylesterase 1) ELISA Kit

Ver Producto
ER0265

Rat Pon1 (Serum paraoxonase/arylesterase 1) ELISA Kit

Ver Producto
FNab06638

PON1 antibody

Hydrolyzes the toxic metabolites of a variety of organophosphorus insecticides. Capable of hydrolyzing a broad spectrum of organophosphate substrates and lactones, and a number of aromatic carboxylic acid esters. Mediates an enzymatic protection of low density lipoproteins against oxidative modification and the consequent series of events leading to atheroma formation.

Ver Producto